Stocks›Consumer Defensive›MEDS

MEDS

DataMeds AI, Inc.

NasdaqResearch view

Consumer Defensive · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Small-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorConsumer Defensive

Market Cap$762.8M

Enterprise Value$797.2M

Income$-101.3M

Sales$23.3M

Book/sh$-4.07

Cash/sh$0.01

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio0.04

Current Ratio0.09

Debt/Eq-2.76

EPS (ttm)$-1.43

EPS this Y-853.3%

EPS past 3/5Y—

Sales past 3/5Y—

EPS Y/Y TTM-853.3%

Sales Y/Y TTM28.7%

Shs Outstand3.06M

ROA-332.5%

ROE813.6%

ROIC-428.4%

Gross Margin-27.5%

Oper. Margin-401.7%

Profit Margin-433.9%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$18.1M

2024

$23.3M

2025

Financials — annual

SEC EDGAR · last 2 FY · tap a row to explain it

USD	FY2024	FY2025
Revenue	$18.1M	$23.3M
Gross Profit	$1.8M	$-6.4M
Operating Income	$-6.1M	$-93.7M
Net Income	$-6.9M	$-101.3M
Diluted EPS	$-0.15	$-1.43
Operating Cash Flow	$-1.2M	$-10.9M
Free Cash Flow	—	—